Further work using transcriptomics will be needed to define the downstream effector molecules differentially and mutually controlled by Jun and Ddit3. In addition to glaucoma-relevant injuries, JUN and DDIT3 have been implicated in other neurodegenerative diseases [42, 60]. This evidence concerns the gene JUN and glaucoma.